This was something that I picked up.
The board recently appointed Torreya, a global investmentbank specialising in life sciences, as Neuren’s corporateadvisor and we are now working closely with Torreya toidentify and evaluate all potential corporate transactionsincluding individual products, territories, or Neuren’sentire business.
First time I can recall any narrative on a potential sale of the business. It will be interesting to see what Torreya can come up with - if anything.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.32 |
Change
0.470(3.66%) |
Mkt cap ! $1.652B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.135M | 315.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41 | $13.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 580 | 3 |
View Market Depth
| Last trade - 11.57am 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |